News
Commercialization agreement with SHIONOGI for DTx for Insomnia
21/12/27

SUSMED and SHIONOGI have entered into commercialization agreement of DTx for Insomnia.

Previous
Back to list
Next
Latest Article
2024/11/07
FISCO Analyst Report
2024/06/05
Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting about our DTx
2024/04/17
Joint research with Nagoya University on predictive model for postpartum depression with machine learning